For laboratory research use only. Not for human consumption.

EU
0
Product | 5% RU-58841 (Topical Serum)

5% RU-58841 (Topical Serum)

5% RU-58841 (Stratum Corneum Research) (PSK-3841) is a synthetic non-steroidal antiandrogen (NSAA) engineered as a high-affinity competitive antagonist of the androgen receptor (AR). By occupying the ligand-binding domain of cellular androgen receptors, RU-58841 blocks endogenous dihydrotestosterone (DHT) and testosterone binding, preventing receptor nuclear translocation and downstream gene transcription in dermal papilla and follicular cell lines.

Log in to view prices

Want to be notified when this product is back in stock?

What is 5% RU-58841 (Stratum Corneum Research)?

5% RU-58841 (Stratum Corneum Research) (known chemically as PSK-3841, HMR-3841, or 4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile) is a pioneer non-steroidal antiandrogen (NSAA). Developed specifically as a localized, high-affinity antagonist of the androgen receptor (AR), RU-58841 exhibits high binding selectivity for AR complexes over other steroid hormone receptors (such as glucocorticoid, estrogen, or progesterone receptors).

Unlike 5α-reductase inhibitors that block the enzymatic conversion of testosterone to dihydrotestosterone (DHT), RU-58841 acts directly at the receptor level. Occupying the ligand-binding domain (LBD) of target cell androgen receptors prevents both DHT and testosterone from forming active transcription complexes, insulating cellular machinery from androgenic signaling without altering systemic 5α-reductase enzyme levels.

Batch-verified for high analytical purity at Modern Aminos, 5% RU-58841 is offered as a standardized reference material for cell culture and biochemical research. Researchers evaluating dermal papilla cell proliferation, sebocyte lipogenesis, and androgen receptor dimerization kinetics utilize RU-58841 alongside complementary tissue-regulatory reference standards available on the site.

Chemical and Molecular Data

Compound Name RU-58841 (PSK-3841 / HMR-3841)
Quantity / Formats Offered 5% RU-58841 in 30mL Amber Bottle with precision 1mL Dropper
Chemical Structure Fluorinated Imidazolidinedione Non-Steroidal Antiandrogen
Synonyms / Alt Names RU58841, PSK-3841, HMR-3841, RU-58841 Base, NSAA RU-58841
CAS Number 154992-24-2
Chemical Formula C17H18F3N3O3
Molecular Weight 369.34 g/mol
IUPAC Name 4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
InChIKey OQVIYIHKXNWXKS-UHFFFAOYSA-N
SMILES Code CC1(C(=O)N(C(=O)N1CCCCO)C2=CC(=C(C=C2)C#N)C(F)(F)F)C
Inert Contents Propylene Glycol, Ethanol

What are the Mechanisms of Action?

The biochemical pathways and cellular targets of RU-58841 in laboratory research include:

  • Competitive Androgen Receptor (AR) Antagonism: RU-58841 binds directly to the ligand-binding domain (LBD) of human androgen receptors with high affinity (Ki ≈ 1.1 nM). Occupancy of the receptor cavity sterically blocks endogenous dihydrotestosterone (DHT) and testosterone from binding.
  • Suppression of AR Dimerization & Nuclear Translocation: Upon binding, RU-58841 prevents conformational shifts required for receptor heat-shock protein (HSP) dissociation, receptor homodimerization, and nuclear translocation. This blocks AR binding to androgen response elements (AREs) on DNA.
  • Local Cellular Receptor Isolation: Because RU-58841 operates strictly via receptor-level competitive blockade, it attenuates local androgenic gene expression in cultured dermal papilla cells and sebocytes without inhibiting 5α-reductase enzymes (5AR1/5AR2) or altering systemic hormone synthesis.

What do Preclinical & Academic Studies Show for RU-58841?

When evaluating research efficacy and published scientific literature for 5% RU-58841 (PSK-3841):

  • Local Antiandrogenic Activity & AR Kinetics (PubMed): Landmark bioenergetic studies cataloged on PubMed (PMID: 9413280) confirm that a 5% RU-58841 (Stratum Corneum Research) exhibits high local antiandrogenic potency, suppressing androgen-dependent organ growth in animal models without displaying systemic hormonal side effects.
  • Dermal Papilla Cell Proliferation & Follicular Assays (PMC): Comprehensive biomedical reviews archived in PMC (PMC3221300) document RU-58841’s capacity to protect cultured human hair follicle cells against DHT-mediated growth arrest and apoptotic signaling cascades.
  • Chemical Profiling & Identification (PubChem): Official structural characterization maintained on PubChem verifies the molecular mass (369.34 g/mol), trifluoromethylbenzonitrile structure, and HPLC mass spectrometry profile of CAS 154992-24-2.

How does RU-58841 compare to other compounds?

To evaluate receptor binding affinity, target specificity, and signaling mechanics, researchers compare 5% RU-58841 against alternative reference standards available at Modern Aminos:

RU-58841 vs. 5α-Reductase Inhibitors

In androgen signaling and cellular pathology research, the site of pathway intervention determines experimental parameters:

  • RU-58841 (Receptor Antagonist): Non-steroidal antiandrogen that directly blocks androgen receptors (AR). Prevents both DHT and testosterone from binding to cellular receptors without inhibiting 5α-reductase enzymes or altering circulating hormone concentrations.
  • 5α-Reductase Inhibitors: Enzymatic inhibitors that block 5AR1/5AR2 conversion of testosterone to DHT. Reduces intracellular DHT concentrations but leaves androgen receptors open to binding by circulating testosterone.
Compound / Reference Chemical Structure & Class Core Mechanism of Action Research Focus & Profile
RU-58841 Fluorinated Imidazolidinedione NSAA Competitive AR antagonist; occupies ligand-binding domain to block DHT and testosterone binding Focuses on androgen receptor isolation, dermal papilla cell protection, AR dimerization inhibition, and NSAA kinetics
Pyrilutamide (KX-826) Second-Generation Non-Steroidal Antiandrogen High-affinity competitive AR antagonist engineered for elevated local binding potency and rapid metabolic clearance Focuses on next-generation AR competitive kinetics, local receptor occupancy, and sebocyte pathway modulation
CB-03-01 (Clascoterone) Steroidal Antiandrogen (Cortexolone Derivative) Competes with DHT for androgen receptor binding at the local tissue level, metabolizing into inactive cortexolone Focuses on steroidal AR competition, local tissue antiandrogenic action, and sebaceous gland signaling assays
GHK-Cu Copper-Chelated Tripeptide (Gly-His-Lys) Upregulates collagen, elastin, and extracellular matrix (ECM) gene networks while stimulating SOD1 antioxidant activity Focuses on tissue remodeling, extracellular matrix synthesis, angiogenesis, and anti-inflammatory signaling

Frequently Asked Questions (FAQs)

1. Is Modern Aminos a reliable place to buy 5% RU-58841 (Stratum Corneum Research)?

Yes, Modern Aminos is a highly trusted vendor for high-purity research chemicals and reference compounds. Every batch of RU-58841 undergoes strict third-party analytical testing (including HPLC and Mass Spectrometry) to verify minimum 98%+ chemical purity, correct molecular weight (369.34 g/mol), exact antiandrogenic structure fidelity, and complete absence of heavy metals or synthesis impurities.

2. What is RU-58841 and how is it classified chemically?

RU-58841 (PSK-3841) is a synthetic fluorinated imidazolidinedione derivative. It is classified chemically as a non-steroidal antiandrogen (NSAA) and competitive androgen receptor antagonist.

3. How does 5% RU-58841 interact with the androgen receptor (AR)?

RU-58841 binds competitively to the ligand-binding domain (LBD) of human androgen receptors with nanomolar affinity (Ki ≈ 1.1 nM). By occupying the receptor site, it prevents endogenous DHT and testosterone from binding and initiating receptor dimerization.

4. How does RU-58841 differ from 5-alpha reductase inhibitors like Finasteride?

Finasteride inhibits the 5α-reductase enzyme to block the conversion of testosterone into DHT. RU-58841 acts directly at the androgen receptor level, blocking both DHT and testosterone from binding to the receptor without altering enzyme activity or hormone synthesis.

5. What role does 5% RU-58841 play in dermal papilla cell research?

In dermal papilla cell cultures, RU-58841 attenuates DHT-induced apoptosis and growth arrest, allowing researchers to study androgen-independent cellular proliferation, protein synthesis, and hair follicle growth dynamics in vitro.

6. How does RU-58841 compare to Pyrilutamide (KX-826) or CB-03-01?

RU-58841, Pyrilutamide (KX-826), and CB-03-01 all function as competitive androgen receptor antagonists. RU-58841 is the classic non-steroidal NSAA reference standard, Pyrilutamide is a high-affinity second-generation NSAA, and CB-03-01 is a steroidal cortexolone-derived antagonist.

7. How does Modern Aminos verify the chemical purity and identity of 5% RU-58841 (Stratum Corneum Research)?

Modern Aminos utilizes High-Performance Liquid Chromatography (HPLC) to confirm active chemical purity exceeding 98% and Mass Spectrometry (MS) to verify exact molecular weight (369.34 g/mol) and structural identity prior to batch release.

8. What are the recommended storage parameters for RU-58841 reference standards?

Reference material should be stored tightly sealed in a cool, dry environment (15°C to 25°C) or refrigerated for long-term preservation. Protect from direct heat, light exposure, and atmospheric moisture to maintain solid-state chemical stability.

DISCLAIMER: All compounds and research materials provided by Modern Aminos are strictly for laboratory and research use only. They are not approved for human consumption by the Food and Drug Administration (FDA). No products are approved for oral, sublingual, nor in vivo use. These products should not be used for any form of in vivo experimentation or for any other non-laboratory purpose. Any violation or indication of human or animal use will result in immediate removal from being able to purchase products in the future. By purchasing these products, you acknowledge that they will be used exclusively within a controlled and qualified research environment.

DISCLAIMER: All compounds and research materials supplied by Modern Aminos are intended exclusively for in vitro laboratory research by qualified professionals. They are not medicinal products and have not been authorised by the European Medicines Agency or any national competent authority for human or veterinary use. They are not foods, food supplements, cosmetics or medical devices. Products must not be administered to humans or animals by any route and must not be used for in vivo experimentation or any other non-laboratory purpose. We will refuse or cancel orders, and may close accounts, where there is any indication of human or animal use. By purchasing, you confirm that products will be used only in a controlled laboratory environment by appropriately qualified personnel, in line with all applicable laws.

Related Products

Disclaimer!

All products are sold in powder (lyophilized) form and require reconstitution with a suitable diluent for research purposes only. Research supplies (e.g., syringes, bacteriostatic water) are not included. No dosing instructions are provided. We adhere to all local and state laws around Research Only Chemical sales. We are not a pharmacy, nor do we promote or provide any advice for human or animal consumption. Please review our terms and conditions carefully before making a purchase on our website.

You must be 21+ and a licensed research professional

By clicking ”I Agree” you confirm that you have read and accepted the Terms and Conditions stated above